Fu-Sen Liang

Fu-Sen Liang

Case Western Reserve University

H-index: 17

North America-United States

About Fu-Sen Liang

Fu-Sen Liang, With an exceptional h-index of 17 and a recent h-index of 12 (since 2020), a distinguished researcher at Case Western Reserve University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Novel combination therapy for treating proteasome inhibitor-resistant multiple myeloma

A theranostic abscisic acid-based molecular glue

Site‐Specific m6A Erasing via Conditionally Stabilized CRISPR‐Cas13b Editor

Tumor therapy compositions and methods

A split CRISPR/Cas13b system for conditional RNA regulation and editing

A CRISPR-based Strategy for Temporally Controlled Site-Specific Editing of RNA Modifications

On demand CRISPR-mediated RNA N6-methyladenosine editing

Inducible and reversible RNA N6-methyladenosine editing

Fu-Sen Liang Information

University

Position

___

Citations(all)

1639

Citations(since 2020)

957

Cited By

1089

hIndex(all)

17

hIndex(since 2020)

12

i10Index(all)

24

i10Index(since 2020)

13

Email

University Profile Page

Case Western Reserve University

Google Scholar

View Google Scholar Profile

Top articles of Fu-Sen Liang

Title

Journal

Author(s)

Publication Date

Novel combination therapy for treating proteasome inhibitor-resistant multiple myeloma

Cancer Research

Byung-Gyu Kim

Sung Hee Choi

Huong Nguyen

Fu-Sen Liang

Seong-Jin Kim

...

2024/3/22

A theranostic abscisic acid-based molecular glue

Chemical Science

Jing Chen

Huong TX Nguyen

Ming Yang

Fangxun Zeng

Hang Xu

...

2023

Site‐Specific m6A Erasing via Conditionally Stabilized CRISPR‐Cas13b Editor

Angewandte Chemie

Ying Xu

Yufan Wang

Fu‐Sen Liang

2023/10/23

Tumor therapy compositions and methods

2023/9/14

A split CRISPR/Cas13b system for conditional RNA regulation and editing

Journal of the American Chemical Society

Ying Xu

Na Tian

Huaxia Shi

Chenwei Zhou

Yufan Wang

...

2023/2/22

A CRISPR-based Strategy for Temporally Controlled Site-Specific Editing of RNA Modifications

Bio-protocol

Ying Xu

Yufan Wang

Fu-Sen Liang

2023/2/2

On demand CRISPR-mediated RNA N6-methyladenosine editing

Genes & Diseases

Ying Xu

Fu-Sen Liang

2022/11

Inducible and reversible RNA N6-methyladenosine editing

Nature Communications

Huaxia Shi

Ying Xu

Na Tian

Ming Yang

Fu-Sen Liang

2022/4/12

MicroRNAs and other noncoding RNAs in human pathology

Umesh Bhattarai

Fu-Sen Liang

2022/1/1

Compositions and methods for controlling cellular function

2023/7/13

Investigating crosstalk between H3K27 acetylation and H3K4 trimethylation in CRISPR/dCas-based epigenome editing and gene activation

Scientific reports

Weiye Zhao

Ying Xu

Yufan Wang

Dan Gao

Jasmine King

...

2021/8/5

Epigenetic control of heparanase expression using CRISPR/dCas9

Cancer Research

Zixin Chen

Guihua Zeng

Xiaogang Li

Fu-Sen Liang

Lina Cui

2021/7/1

Bifunctional small molecule-oligonucleotide hybrid as microRNA inhibitor

Bioorganic & medicinal chemistry

Umesh Bhattarai

Wei-Che Hsieh

Hao Yan

Zhi-Fo Guo

Ashif Yasin Shaikh

...

2020/4/1

Chemical and light inducible epigenome editing

Weiye Zhao

Yufan Wang

Fu-Sen Liang

2020/2/3

See List of Professors in Fu-Sen Liang University(Case Western Reserve University)